About this trial
The main objective of this study is to test the ability of novel cardiovascular disease (CVD) prognostic tools to identify women at risk for future CVD. We plan to establish a cardiovascular health screening program at the St. Boniface Hospital and to test the efficacy of these tests for predicting adverse cardiovascular outcomes amongst a cohort of 1000 Manitoban women aged 55 years and older in the 5-year period after screening.
A second purpose of this project is to identify novel CVD biomarkers that may indicate a person is at risk for cardiovascular disease. Therefore, we plan to ask participants for permission to collect and store a sample of both their blood and stool for future research.
Eligibility criteria
Qualifiers
women aged 55 and older
possess a Manitoba Personal Health Information Number
Disqualifiers
Ischemic heart disease
Acute myocardial infarction
Stroke/Transient ischemic attack
Percutaneous coronary intervention
Trial design
Treatments tested in this trial
- Not listed